The hospital staffing crunch that throttled medical device sales in recent quarters has eased, according to
Johnson & Johnson
chief financial officer, sending procedure volumes back up, and leading to an 8.1% increase in adjusted operational sales in the company’s medical devices division in the last quarter.
Johnson & Johnson (ticker: JNJ) posted adjusted earnings of $2.55 a share early Tuesday, on sales of $23.8 billion. Analysts surveyed by FactSet had expected the healthcare giant to report earnings of $2.48 a share on revenue of about $23.4 billion.
